Patient perspectives on living with severe asthma in Denmark and Sweden
- PMID: 33414901
- PMCID: PMC7751392
- DOI: 10.1080/20018525.2020.1856024
Patient perspectives on living with severe asthma in Denmark and Sweden
Abstract
Background: Severe asthma has an acknowledged impact on health-related quality of life (HRQOL) and is associated with substantial health care costs. This study aimed to investigate the patients' own experiences of the disease, perceptions of HRQOL, and awareness of disease management. Methods: This study included severe asthma patients in Sweden and Denmark. A quantitative Web-based survey and qualitative in-depth interviews (IDIs) were conducted. The survey included St. George's Respiratory Questionnaire (SGRQ), Asthma Control Test (ACT), Work Productivity and Activity Impairment (WPAI), and a study-specific questionnaire on quality of care and disease awareness. Telephone-based IDIs were conducted by medical interviewers following a semi-structured interview guide. Results: A total of 93 patients participated in the Web survey, and 33 participated in the IDIs. In the survey, the vast majority (77%; 72/93) had uncontrolled asthma (ACT<20). Mean total SGRQ score was 47.4 (59.7 symptom, 53.7 activity, 39.9 impact scores). Nearly 60% were treated in primary care. The IDIs revealed a long path to diagnosis, substantial and constant need for adaptations because of disease limitations, high burden on family members, social restrictions, and sick leaves and income losses. Patient awareness about guidelines, treatment goals, and available therapies was poor, and a low level of satisfaction by primary health care was seen. Conclusions: The vast majority of this severe asthma population had uncontrolled asthma and poor access to lung expert physicians. Impaired HRQOL despite patients' adaptations was indicated. These findings highlight the need for structured patient education and greater access to units with disease-specific knowledge.
Keywords: Asthma control; patient perspective; patient-reported outcomes; severe asthma.
© 2020 Informa UK Limited, trading as Taylor & Francis.
Conflict of interest statement
GP has received Principal Investigator fees by AstraZeneca. She has also participated in advisory boards for AstraZeneca and Novartis. AT has participated in advisory boards and provided medical expertise against remuneration for medical staff in the fields of allergy, asthma and COPD, sponsored by AstraZeneca, GSK, Boehringer Ingelheim, MSD, ALK, Novartis, Mundipharma, Nycomed, Sanofi, Teva, Almirall Nordic, and AGA. JB has participated in studies sponsored by AstraZeneca and Viscogel. He has been Scientific consultant for AstraZeneca. GT are employed by AstraZeneca. KR has collaborated with AstraZeneca, GSK, Chiesi, Boehringer-ingelheim, Mundipharma and Teva, supporting education and projects in respiratory medicine. He has also participated in advisory boards for the same companies.
Figures
Similar articles
-
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY.J Asthma Allergy. 2023 Jun 11;16:611-624. doi: 10.2147/JAA.S401445. eCollection 2023. J Asthma Allergy. 2023. PMID: 37334017 Free PMC article.
-
Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma.J Asthma Allergy. 2021 Jun 25;14:713-725. doi: 10.2147/JAA.S305513. eCollection 2021. J Asthma Allergy. 2021. PMID: 34211280 Free PMC article.
-
Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.Respir Med. 2017 May;126:32-38. doi: 10.1016/j.rmed.2017.02.021. Epub 2017 Feb 28. Respir Med. 2017. PMID: 28427547
-
[Illness specific data collection on quality of life of patients with asthma and chronic obstructive bronchitis].Rehabilitation (Stuttg). 1998 Aug;37(3):XXV-XXXVIII. Rehabilitation (Stuttg). 1998. PMID: 9789318 Review. German.
-
Living well with severe asthma.Breathe (Sheff). 2019 Jun;15(2):e40-e49. doi: 10.1183/20734735.0165-2019. Breathe (Sheff). 2019. PMID: 31777564 Free PMC article. Review.
Cited by
-
Patient-centred outcomes in severe asthma: fatigue, sleep, physical activity and work.Eur Respir Rev. 2025 Mar 5;34(175):240122. doi: 10.1183/16000617.0122-2024. Print 2025 Jan. Eur Respir Rev. 2025. PMID: 40044187 Free PMC article. Review.
-
Quality of life and work functionality in severe asthma patients: the impact of biological therapies.J Occup Med Toxicol. 2024 Mar 20;19(1):8. doi: 10.1186/s12995-024-00406-9. J Occup Med Toxicol. 2024. PMID: 38509562 Free PMC article.
References
-
- Global Asthma Network. The global asthma report 2019. Available from: GINA-2019-main-report-June-2019-wms.pdf
-
- Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–7. - PubMed
-
- O’Byrne PM, Pedersen S, Schatz M, et al. The poorly explored impact of uncontrolled asthma. Chest. 2013;143(2):511–523. - PubMed
-
- von Bulow A, Kriegbaum M, Backer V, et al. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759–767. - PubMed
LinkOut - more resources
Full Text Sources